The next step in this ongoing research project involved translating the findings from basic research into applied clinical research with experimental treatment
of human cancer patients.
The use of bone marrow - derived stem cells is well established in the treatment
of human cancer patients, and veterinary applications for bone marrow - and adipose - derived stem cells are being evaluated.
Not exact matches
In 2000, Medarex began its first phase
of human testing on its new «CTLA -4-blockade» — in
patients who had either prostate
cancer or metastatic melanoma, a deadly form
of skin
cancer.
«Our results suggest that engineered
human intestine could provide a viable treatment to lengthen the gut for
patients with gastrointestinal disorders, or
patients who lose parts
of their intestines due to
cancer,» said Bitar.
A dozen
human studies
of MDMA, LSD, a powerful African drug called ibogaine and psilocybin, from so - called «magic mushrooms,» are now under way, testing the once - stigmatized drugs as treatments for not only PTSD, but also cluster headaches and addiction, as well as anxiety and depression in
cancer patients.
HBI member V. Wee Yong, PhD and research associate Susobhan Sarkar, PhD, and their team including researchers from the Department
of Clinical Neurosciences and the university's Southern Alberta
Cancer Research Institute, looked at
human brain tumor samples and discovered that specialized immune cells in brain tumor
patients are compromised.
«Data from this study serves as rationale to now include dogs with spontaneous
cancers in the advancement and optimization
of PMed for
human patients,» according to the study, Prospective molecular profiling
of canine
cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials.
If further research confirms the findings in
human cells, limiting the amount
of asparagine
cancer patients ingest could be a potential strategy to augment existing therapies and to prevent the spread
of breast
cancer, Knott added.
By promoting DNA demethylation, high - dose vitamin C treatment induced stem cells to mature, and also suppressed the growth
of leukemia
cancer stem cells from
human patients implanted in mice.
Pre-clinical studies have shown it to be effective in eliminating a number
of different kinds
of cancers cells, including
cancer stem cells from
human breast
cancer patient biopsies.
Researchers have isolated exosomes from tumors and from blood
of patients with breast
cancer, and from blood
of mice with
human tumors grown after breast implantation in mice, called ortoxenogratfs.
Those false lines were used in the early trials
of two drugs that were later tested in
human patients with thyroid
cancer.
To that end, in collaboration with the University
of Zurich and MD Anderson
Cancer Center, the researchers tested melanoma tumor samples from
human patients undergoing treatment with the same targeted therapies.
In this study, researchers took cells from
patients with blood
cancer MDS and turned them into stem cells to study the deletions
of human chromosome 7 often associated with this disease.
They found out that TiY is capable
of distinguishing TICs from non-TICs in various
human lung
cancer cell lines and
patient - derived lung tumors.
By assessing the survival
of the cells that engulf the particles and measuring the levels
of red or green light that they emitted, the researchers determined which formulation
of particles performed best, then tested that formulation in mice with
human brain
cancer derived from their
patients.
«Next steps are to further explore this possibility in
human trials in order to assess if it will help
patients, but these two drugs make sense from a variety
of studies and we find that they act together through multiple mechanisms to control
cancer growth in the laboratory.»
Horvath and Tell's research is the first reported study to compare breast
cancer subtypes and gene expression patterns associated with STAT3 in the tumors
of human patients.
A small dose
of 1.56 µM, which is approximately equivalent to a daily dose
of the drug in a
human cancer patients, increased the fruit flies» average life expectancy by 8 %.
When his team looked at gene expression changes in the mice, then applied them to
humans with early stage
cancer, the results revealed a breakdown
of which
patients have a high or low chance
of survival.
Additional experiments using a combination
of maraviroc and a drug that blocks the VEGF protein suggest that the treatment duo could be an effective way to prevent metastatic disease in
human breast
cancer patients, according to the researchers.
Nagrath, director
of Rice's Laboratory for Systems Biology
of Human Diseases, said the new metabolic analysis indicates that ovarian
cancer may be susceptible to multidrug cocktails, particularly if the amounts
of the drugs can be tailored to match the metabolic profile
of a
patient's tumor.
«By helping us understand that lower levels
of RNF125 confer resistance to BRAF inhibitors, we have a new strategy to stratify
patients for currently approved therapy versus participation for
human clinical trials to investigate whether targeting JAK1 will be more effective in
patients whose tumors exhibit reduced RNF125,» said Keith T. Flaherty, M.D., associate professor, Harvard Medical School, and director
of Developmental Therapeutics,
Cancer Center, Massachusetts General Hospital, and co-author
of the study.
In a second group
of experiments using
human tissue from
patients with pancreatic ductal adenocarcinoma, which accounts for more than 90 percent
of pancreatic
cancers, Zheng and his colleagues also tracked down a link between the abundance
of Sema3D in those tissues and the progression
of metastatic pancreatic
cancer.
Published in the Journal
of Clinical Investigation, the study collected metabolic data directly from more than 120
human lung
cancer patients.
Spouses and long - term partners
of patients with mouth and throat
cancers related to infection with the
human papilloma virus (HPV) appear to have no increased prevalence
of oral HPV infections, according to results
of a multicenter, pilot study led by Johns Hopkins investigators.
«We now know much more about metabolic reprogramming
of cancerous tissues in
human patients, particularly that the activation
of pyruvate carboxylase is important to lung
cancer cell growth and survival,» said Fan, UK professor of toxicology and faculty member of the Markey Cancer Center and CESB at the University of Ken
cancer cell growth and survival,» said Fan, UK professor
of toxicology and faculty member
of the Markey
Cancer Center and CESB at the University of Ken
Cancer Center and CESB at the University
of Kentucky.
In his current position at The Jackson Laboratory, he has overall responsibility for the ongoing operational development
of the PDX resource, which generates, banks, and distributes
patient - derived xenograft (PDX) mouse models
of human cancers.
For example, although early clinical trials
of Listeria - based vaccines have shown that the neutralized bacterium produces only mild flulike symptoms in
human patients with cervical
cancer, the various methods
of genetically disarming the bacteria should be explored to find the safest approach for people gravely ill with pancreatic
cancer, because these
patients are likely to already have weak immune systems.
That finding indicates that very low numbers
of the cells in the body could be enough to protect
human patients from maladies ranging from infections to
cancer.
In previous studies, including recent genome sequencing
of cancer patients,
human SETD2 has been implicated in several
cancer types, especially in renal cell carcinoma — the most common kind
of kidney
cancer.
«We found that a comprehensive exercise and diet program in a group setting can make a difference for prostate
cancer patients, and the difference was greater than I expected in a short period
of time,» said lead author Brian Focht, a professor
of human sciences at Ohio State.
Over the past two years, investigators from the Perelman School
of Medicine at the University
of Pennsylvania have reported results from a
human trial in GBM using chimeric antigen receptor (CAR) T cell therapy, through which
patients» own T cells were engineered to track down and kill
cancer cells that express a tumor - specific protein known as EGFRvIII.
Sood and colleagues looked at samples from 80 cases
of human ovarian
cancer grouped according to
patient stress using the National Institutes
of Health's Center for Epidemiological Studies Depression scale as a surrogate marker.
The existence
of cancer stem cells has already been reported in a number
of human cancers, explains Professor Jacobsen, but previous findings have remained controversial since the lab tests used to establish the identity
of cancer stem cells have been shown to be unreliable and, in any case, do not reflect the «real situation» in an intact tumour in a
patient.
In a letter published in the
cancer journal Annals
of Oncology, researchers led by Professor Jean - Philippe Spano, head
of the medical oncology department at Pitie - Salpetriere Hospital AP - HP in Paris, France, report that while treating an HIV - infected lung
cancer patient with the
cancer drug nivolumab, they observed a «drastic and persistent decrease» in the reservoirs
of cells in the body where the
human immunodeficiency virus (HIV) is able to hide away from attack by anti-retroviral therapy.
Researchers from Uppsala University, Sweden, and the Broad Institute, USA, have identified both similarities and differences between a single tumor type in multiple dogs breeds; a finding they believe parallels the situation in the
cancer of human patients.
Researchers suggested that other classes
of inhibitors be tested in combination with ERK5 inhibitors in
human colorectal
cancer cells in preclinical mouse models before any
patient trial can begin.
Of note, 145 of all the oropharyngeal cancer patients were also tested for human papillomavirus (HPV), allowing researchers to compare possible associations between the two viruse
Of note, 145
of all the oropharyngeal cancer patients were also tested for human papillomavirus (HPV), allowing researchers to compare possible associations between the two viruse
of all the oropharyngeal
cancer patients were also tested for
human papillomavirus (HPV), allowing researchers to compare possible associations between the two viruses.
Since the thyroid absorbs nearly all
of the iodine in the
human body, radioactive iodine given to a
patient will concentrate in thyroid
cancer cells, killing them with little effect on the rest
of the body.
If borne out in
humans, the findings caution against giving this type
of antioxidant - containing medication to diabetic
cancer patients.
«More research is needed to evaluate the efficacy
of this use
of a
cancer medication to alleviate risk
of sudden cardiac death, but we are hopeful that what we observed in mice will translate effectively to
humans, providing
patients and clinicians with a new paradigm for treating this common and life - threatening illness,» Dudley said.
If it works in
humans, the technique could prolong the lives
of some brain
cancer patients, and it might be applicable to other types
of cancer as well.
«Liver
cancer is on the rise worldwide, and in
human studies we've now seen that
patients can progress from fatty liver disease to liver
cancer without any middle steps such as cirrhosis,» says David Moore, a professor
of molecular and cellular biology, who led the study with Associate Professor Loning Fu, both at Baylor.
Buoyed by these results, Dana - Farber researchers are working to create a derivative
of dBET1 that can be used as a drug in
human patients — and to extend the conjugate strategy for the treatment
of other
cancers and other genetically - caused diseases.
After confirming in mouse models that cells from HER2 - positive breast
cancers became resistant to anti-HER2 treatment when implanted into the brain but not into other tissues, the investigators found that HER3 is overexpressed in brain metastases
of HER2 - positive breast
cancers from both mice and
human patients.
«If the mouse models are indicative
of human disease, the combination therapy can increase the proportion
of patients who respond to therapy without additional adverse side effects and can improve the quality
of life for
cancer patients.»
But a new study
of dogs with tumors — as well as one
human cancer patient — reveals that injecting certain bacteria directly into the growths can shrink or even eliminate them.
«Based on this research, we are now conducting a first - in -
human study combining the PARP inhibitor with radiation and chemotherapy in
patients with locally advanced pancreatic
cancer, with an ultimate goal
of improving survival rates and treatment outcomes,» said Tuli.
BOSTON — A heated discussion broke out here today at the annual meeting
of the American Society
of Human Genetics over a hot - button topic: When will we know enough about rare
cancer risk genes to begin routinely testing for them in
patients with a family history
of cancer?